Home
Scholarly Works
Phase II testing of lenalidomide plus melphalan...
Conference

Phase II testing of lenalidomide plus melphalan for previously untreated older patients with multiple myeloma: Toxicity data from the NCIC CTG MY.11 trial

Authors

White DJ; Kovacs MJ; Belch A; Stewart K; Chen C; Rubin S; Macdonald DA; Harnett E; Chapman J-AW; Shepherd LE

Volume

110

Pagination

pp. 63A-63A

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 16, 2007

Name of conference

49th Annual Meeting of the American-Society-of-Hematology

Conference place

Atlanta, GA

Conference start date

December 8, 2007

Conference end date

December 11, 2007

Conference proceedings

BLOOD

Issue

11

ISSN

0006-4971

Contact the Experts team